Leveraging discovery to improve human health “Across the Lifespan”

Researchers collaborate to treat vision loss linked to Usher thanks to a 1.74 million USD grant from the National Institutes of Health

The elderly are often prescribed multiple medications for different health conditions. While some medications are needed, polypharmacy and medication overload can be costly and even harmful.

The MUHC received the 3T GE SIGNA™ Premier, a flagship GE Medical Systems Cardiac Magnetic Resonance (MR) machine, on Saturday, September 21, 2019

Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?

How exactly does a normal cell become a tumour?

Researchers uncover new protein that plays key role in bacterial infections

Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population

Rates of colonization of two health-associated infections tumbled soon after historic hospital move

Marina Klein co-leads initiative to make Montreal the first city in North America to eliminate hepatitis C

Dr. Yoanna Skrobik is co-author of an editorial in the New England Journal of Medicine

Dr. Natalie Dayan studies how heart problems in pregnant women can sometimes impact them for life

Lung function normally declines as we age, but a new study suggests that air pollution may contribute to this process

People with fibromyalgia show variations in microbiome composition

A longitudinal study led by RI-MUHC researcher Deborah Da Costa investigates an important predictor of pregnancy outcomes

Heart & Stroke and McGill University to create Early-Career Professorship in Women’s Heart Health

RI-MUHC is part of a Quebec-wide collaborative effort to provide oncology innovation and discovery pipeline

Technology and patient insight at the heart of innovative patient portal developed at the MUHC

New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction

A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection